PNC Financial Services Group
DCPH

PNC Financial Services Group’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

PNC Financial Services Group’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-599
Closed -$9.42K – 4951
2024
Q1 		$9.42K Buy
599
+44
+8% +$677 ﹤0.01% 3773
2023
Q4 		$8.95K Sell
555
-267
-32% -$3.41K ﹤0.01% 3764
2023
Q3 		$10.5K Buy
822
+217
+36% +$2.99K ﹤0.01% 3745
2023
Q2 		$8.52K Hold
605
– – ﹤0.01% 3945
2023
Q1 		$9.35K Sell
605
-185
-23% -$3.09K ﹤0.01% 3837
2022
Q4 		$12.9K Buy
790
+738
+1,419% +$12K ﹤0.01% 3665
2022
Q3 		$1K Hold
52
– – ﹤0.01% 4371
2022
Q2 		$1K Hold
52
– – ﹤0.01% 4395
2022
Q1 		$0 Buy
52
+29
+126% +$247 ﹤0.01% 4748
2021
Q4 		$0 Buy
23
+8
+53% +$150 ﹤0.01% 4657
2021
Q3 		$1K Buy
+15
New +$479 ﹤0.01% 4234
2020
Q1 		– Sell
-19
Closed -$1K – 4089
2019
Q4 		$1K Buy
+19
New +$903 ﹤0.01% 3917

Other funds holding DCPH

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

PNC Financial Services Group's DCPH Position: Q2 2024 in Review

PNC Financial Services Group sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 599 shares — an estimated $9.42K sold.

PNC Financial Services Group first reported a position in DCPH in Q4 2019 and held it in 12 quarters. The position peaked at $12.9K in Q4 2022. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

  • PNC Financial Services Group reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • PNC Financial Services Group sold 599 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $9.42K.
  • PNC Financial Services Group first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 12 quarters.
  • PNC Financial Services Group's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $12.9K in Q4 2022.
  • 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on PNC Financial Services Group's 13F filing for Q2 2024, filed 9 Aug 2024.